LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Timepoint Timepoint Unit Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Relative Growth Rate After Treatment
BT-20 LDN-193189
0.04
uM
LJP5
72
hr
1657 5401 5505 0.9811 0.9730
BT-20 Nilotinib
3.33
uM
LJP5
72
hr
1657 5576 5505 1.0129 1.0185
BT-20 Dactolisib
3.33
uM
LJP5
72
hr
1657 1806 5505 0.3282 0.0387
BT-20 WH-4-025
0.37
uM
LJP5
72
hr
1657 3593 5505 0.6527 0.5031
BT-20 SB590885
0.04
uM
LJP5
72
hr
1657 5376 5505 0.9765 0.9663
BT-20 XMD16-144
0.37
uM
LJP5
72
hr
1657 2144 5505 0.3894 0.1264
BT-20 Brivanib
0.37
uM
LJP5
72
hr
1657 5313 5505 0.9651 0.9501
BT-20 Buparlisib
0.37
uM
LJP5
72
hr
1657 3669 5505 0.6665 0.5229
BT-20 BX-912
0.37
uM
LJP5
72
hr
1657 5456 5505 0.9910 0.9872
BT-20 NVP-AEW541
0.12
uM
LJP5
72
hr
1657 5821 5505 1.0573 1.0820
BT-20 SB590885
0.12
uM
LJP5
72
hr
1657 5393 5505 0.9795 0.9707
BT-20 CGP60474
0.37
uM
LJP5
72
hr
1657 1541 5505 0.2800 -0.0303
BT-20 PIK-93
0.12
uM
LJP5
72
hr
1657 5535 5505 1.0054 1.0078
BT-20 LDN-193189
0.37
uM
LJP5
72
hr
1657 5405 5505 0.9818 0.9739
BT-20 CP724714
0.37
uM
LJP5
72
hr
1657 4890 5505 0.8882 0.8401
BT-20 CP466722
0.37
uM
LJP5
72
hr
1657 5847 5505 1.0620 1.0887
BT-20 Crizotinib
0.37
uM
LJP5
72
hr
1657 4808 5505 0.8733 0.8187
BT-20 Momelotinib
0.37
uM
LJP5
72
hr
1657 4385 5505 0.7965 0.7089
BT-20 Dasatinib
0.37
uM
LJP5
72
hr
1657 1894 5505 0.3440 0.0614
BT-20 Luminespib
0.12
uM
LJP5
72
hr
1657 1796 5505 0.3263 0.0361
BT-20 Dovitinib
0.37
uM
LJP5
72
hr
1657 3165 5505 0.5749 0.3918
BT-20 Enzastaurin
0.37
uM
LJP5
72
hr
1657 6128 5505 1.1130 1.1617
BT-20 Erlotinib
0.37
uM
LJP5
72
hr
1657 5023 5505 0.9123 0.8746
BT-20 Foretinib
0.37
uM
LJP5
72
hr
1657 3174 5505 0.5766 0.3942
BT-20 PLX-4720
3.33
uM
LJP5
72
hr
1657 4095 5505 0.7438 0.6334